Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic
Background: Inflammatory bowel disease (IBD) involves chronic inflammation of the digestive tract. In the past decades, fecal calprotectin has been proposed as a useful biomarker for the differential diagnosis between IBD patients and healthy controls. We designed this study to evaluate the diagnost...
Saved in:
Main Authors: | Soheila Moein (Author), Durdi Qujeq (Author), Mostafa Vaghari Tabari (Author), Mehrdad Kashifard (Author), Karimollah Hajian (Author) |
---|---|
Format: | Book |
Published: |
Babol University of Medical Sciences,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sensitivity and specificity of mean platelet volume as a laboratory marker for irritable bowel syndrome: Can it be added to Rome criteria?
by: Mostafa Vaghari-Tabari, et al.
Published: (2020) -
Value of fecal calprotectin in the diagnosis of chronic inflammatory bowel diseases in children
by: T.V. Yaroshevska, et al.
Published: (2018) -
Impact of Fecal Calprotectin Measurement for Inflammatory Bowel Disease in Children with Alarm Symptoms
by: Burcu Güven, et al.
Published: (2022) -
Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
by: Cao Y, et al.
Published: (2021) -
Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease
by: Andrew S. Day, et al.
Published: (2017)